Piper Jaffray Remains Bullish on CryoLife (CRY) Following 2Q Report

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. SPY
7. CVS
8. UNH
9. DAL
10. TMUS

Go back to Piper Jaffray Remains Bullish on CryoLife (CRY) Following 2Q Report

CryoLife Reports Second Quarter 2016 Financial Results

July 25, 2016 5:34 PM EDT

ATLANTA, July 25, 2016 /PRNewswire/ --

Second Quarter Highlights:

Revenue Increased 33 Percent Year-over-Year to $47.1 Million; Non-GAAP Revenues Increased Nine Percent Year-over-Year Gross Margins Increased to 64 Percent; Non-GAAP Gross Margins Increased to 66 Percent GAAP Net Income was $2.3 Million, or $0.07 Per Fully Diluted Common Share; Non-GAAP Net Income was $4.3 Million, or $0.13 Per Fully Diluted Common share

CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today its results for the second quarter and first half of... More